Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisTwo case reports of neuroinvasive west nile virus infection in the critical care unitChemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infectionLimited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell CultureWest Nile Virus in Europe and Safety of Blood TransfusionWest Nile encephalitisAlpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survivalProtective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virusWest Nile virus. Update for family physiciansWest Nile virus. Primer for family physiciansPathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral EvasionWest Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKRWest Nile virus surveillance and diagnostics: A Canadian perspectiveIdentification of Novel Small-Molecule Inhibitors of West Nile Virus InfectionThe engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophagesDrak2 contributes to West Nile virus entry into the brain and lethal encephalitisWhy the West in West Nile virus infections?The structural immunology of antibody protection against West Nile virusToll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and HomingProgress on the development of therapeutics against West Nile virusIdentification of Inhibitors of Yellow Fever Virus Replication Using a Replicon-Based High-Throughput AssayToll-like receptor 7-induced immune response to cutaneous West Nile virus infectionLocalization of West Nile Virus in monkey brain: double staining antigens immunohistochemically of neurons, neuroglia cells and West Nile VirusA Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-EscapeEvasion of innate and adaptive immunity by flavivirusesToll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitisIdentification and characterization of inhibitors of West Nile virus.A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro.Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus.Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in miceGenome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection.Innate immune control of West Nile virus infection.West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication.West Nile virus: a growing concern?Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.Development of effective therapies against West Nile virus infection.Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis.West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safetyDifferential virulence and pathogenesis of West Nile viruses.
P2860
Q21132564-0FEFB862-E704-460B-AFF7-42E5794B63FFQ21284954-C077FC43-50B9-467A-B3FF-08834DD18ED2Q24646031-DB64EAED-4BA9-4C74-8043-830F2B5C5406Q26699999-4711076F-BC9F-499F-B32D-676DEF487DBCQ26741185-3C1A4D1C-679C-43D3-A50E-F44C142E5966Q27469711-12B0FEA1-9787-435F-B27A-E8DFBB4AA1EFQ27472671-F48EA174-ACE5-405A-BDBB-EAB517E73B7AQ27472711-8566DD62-1EB1-4A71-8B69-7D2DA52DFF84Q27473254-5138BAC5-9E1C-4E79-9B20-607E0C5C2EF4Q27473255-9175070D-5BF6-4A75-8822-CE5D0FABB375Q27477543-F39A3FE9-4FE1-496A-A555-0BA38AEE6BFDQ27481501-53285E09-5BD9-496F-99BE-CEF15862345DQ27481984-3932DCEE-D4F5-40AF-8FFA-AE38DAF6FDB6Q27484983-C5EF8ED6-A965-4B2D-A257-7787140771A5Q27485769-78100358-04C0-49C2-944B-C1FACD27B95AQ27486589-0FC0E13F-D50B-4011-99E9-519CBEBB6008Q27486823-7AB8B15D-135F-401D-8F84-1D85056B315FQ27487955-33CFF330-97F9-4BD3-B5E3-695A01E5C1C5Q27488876-5AE62E26-A82B-4805-B075-5AD47D1AE2FDQ27489893-79A1E9F5-C8FB-4493-B66C-702A42B82D14Q27490191-9AE70B18-2507-4804-9C8F-7C94991BC4CCQ27490290-76EA756D-DFEF-40D1-A942-826404EDFD16Q27490829-67E54E65-1D87-4B6E-B61D-612EA43469B4Q27664656-8B76EDE2-D8CE-44F6-B7A1-A8BC02FAF871Q28204656-3C93A4BC-37AB-4DBD-A098-2D9690746D2AQ29615108-FD3AACF2-CCAD-42D9-86BB-4D3B3DC5E80CQ33462229-0F2014F8-52CA-4688-ABE1-DA11A29B2F6FQ33940722-AB59FDDA-9C73-4DB7-B9B7-ACF6F6B8E5E0Q34027274-89C0361A-1DC3-4582-8CFA-7F09225C1264Q34603029-517A6DAE-0F3D-442C-9723-496351BC40A0Q35097100-D0A9F4CF-FAE0-4CE5-A4F9-E196C9F4DC90Q35382179-94D67842-C881-4EB5-A425-E59BF4E0A83BQ35549286-5FDE4697-E207-4D71-B3B7-B86ACD8F54B8Q35702678-6BBC7B77-6A62-4046-BC9B-580FED579935Q35746093-ABE5FCFA-4918-45B7-9D7A-05657F9D25ABQ36255087-DB074DAF-6539-4D80-9767-8013D4E27578Q36322125-B548C93A-8872-444C-BC6F-5F9E46D1FAF3Q36322559-190975D9-DB9C-4F3C-A020-43219EB47E99Q37306783-486B0B44-F053-4760-80D6-D71D5840AE04Q37376398-11A5DDB2-AFC4-419B-9D51-93F56BF1E0CF
P2860
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@ast
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@en
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@nl
type
label
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@ast
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@en
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@nl
prefLabel
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@ast
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@en
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@nl
P2860
P3181
P356
P1476
Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro
@en
P2093
James J Rahal
John F Anderson
P2860
P3181
P356
10.3201/EID0801.010252
P577
2002-01-01T00:00:00Z